BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Neurocampus - ECPv4.9.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Neurocampus
X-ORIGINAL-URL:https://www.bordeaux-neurocampus.fr/en/
X-WR-CALDESC:Events for Bordeaux Neurocampus
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20190628T143000
DTEND;TZID=Europe/Paris:20190628T143000
DTSTAMP:20260415T092936
CREATED:20190614T145434Z
LAST-MODIFIED:20190614T151159Z
UID:108330-1561732200-1561732200@www.bordeaux-neurocampus.fr
SUMMARY:Conference Labex Trail - Goran Angelovski
DESCRIPTION:Venue : CGFB \n\nGoran Angelovski\nPriv.-Doz. Dr. MR Neuroimaging Agents\,\nMPI for Biological Cybernetics\,\nTuebingen\, Germany \nInvited by Yannick Crémillieux\nDR CNRS ISM (UMR 5255)\nUniversité de Bordeaux \nGoran ANGELOVSKI received a diploma degree from the University in Belgrade\, Ph.D. degree from the University in Dortmund and venia legendi (habilitation) from the University of Tuebingen. He is currently a research group leader at the MPI for Biological Cybernetics in Tuebingen. His research interests include the development of responsive molecular probes for functional MRI applications\, from their preparation\, to the final in vivo utilization. \nAbstract\nMolecular fMRI with Bioresponsive Probes Bioresponsive or smart contrast agents (SCAs) can substantially improve specificity of magnetic resonance imaging (MRI) in studying processes on molecular and cellular level. These probes are capable of alternating the MR image contrast upon change in the local environment\, thus reporting the occurrence of a particular physiological or pathological process. Over the past several years\, we developed a series of paramagnetic and biocompatible SCAs that strongly respond to calcium ions and amino acid neurotransmitters. Moreover\, we validated their functionality in various MRI experiments in vitro\, ex vivo\, as well as in vivo. The most prominent example is utilization of a calcium-sensitive MRI probe for early detection and monitoring of brain ischemia. Wider involvement of this novel fMRI methodology can offer excellent perspectives for direct visualization and mapping of neural activity in unprecedented fashion. \n
URL:https://www.bordeaux-neurocampus.fr/en/event/conference-labex-trail-goran-angelovski/
CATEGORIES:Other events
END:VEVENT
END:VCALENDAR